J Biggs

1.2k total citations
17 papers, 1.0k citations indexed

About

J Biggs is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, J Biggs has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 6 papers in Oncology and 4 papers in Genetics. Recurrent topics in J Biggs's work include Immune Cell Function and Interaction (11 papers), Immunotherapy and Immune Responses (11 papers) and T-cell and B-cell Immunology (9 papers). J Biggs is often cited by papers focused on Immune Cell Function and Interaction (11 papers), Immunotherapy and Immune Responses (11 papers) and T-cell and B-cell Immunology (9 papers). J Biggs collaborates with scholars based in United States, Germany and Australia. J Biggs's co-authors include Linda A. Sherman, Matthias Theobald, Arnold J. Levine, Javier Hernández, Dirk P. Dittmer, Joseph Lustgarten, Timothy Burke, Michael A. Lyman, Eric G. Pamer and Samit Chattopadhyay and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

J Biggs

17 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Biggs United States 13 902 412 299 150 95 17 1.0k
B. Van den Eynde Belgium 7 1.4k 1.5× 640 1.6× 499 1.7× 154 1.0× 149 1.6× 14 1.6k
C.J.M. Melief Netherlands 11 732 0.8× 405 1.0× 289 1.0× 158 1.1× 72 0.8× 16 951
Judith A. Kantor United States 14 414 0.5× 280 0.7× 322 1.1× 132 0.9× 89 0.9× 18 695
Franco Marincola United States 14 1.1k 1.2× 627 1.5× 385 1.3× 96 0.6× 54 0.6× 20 1.3k
Tatiana Zorina United States 6 1.1k 1.2× 373 0.9× 474 1.6× 117 0.8× 49 0.5× 9 1.2k
Ina Haendle Germany 8 1.4k 1.6× 607 1.5× 690 2.3× 91 0.6× 55 0.6× 9 1.6k
Athanasia Syrengelas United States 6 590 0.7× 259 0.6× 246 0.8× 79 0.5× 219 2.3× 6 764
Beatrice Thurner Germany 5 1.4k 1.6× 532 1.3× 653 2.2× 99 0.7× 47 0.5× 5 1.5k
Teresa Rasalan United States 12 953 1.1× 742 1.8× 293 1.0× 77 0.5× 63 0.7× 17 1.2k
Jana Šímová Czechia 15 533 0.6× 269 0.7× 231 0.8× 108 0.7× 30 0.3× 63 723

Countries citing papers authored by J Biggs

Since Specialization
Citations

This map shows the geographic impact of J Biggs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Biggs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Biggs more than expected).

Fields of papers citing papers by J Biggs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Biggs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Biggs. The network helps show where J Biggs may publish in the future.

Co-authorship network of co-authors of J Biggs

This figure shows the co-authorship network connecting the top 25 collaborators of J Biggs. A scholar is included among the top collaborators of J Biggs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Biggs. J Biggs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lyman, Michael A., et al.. (2005). The Fate of Low Affinity Tumor-Specific CD8+ T Cells in Tumor-Bearing Mice. The Journal of Immunology. 174(5). 2563–2572. 47 indexed citations
2.
Lyman, Michael A., Sandra Aung, J Biggs, & Linda A. Sherman. (2004). A Spontaneously Arising Pancreatic Tumor Does Not Promote the Differentiation of Naive CD8+ T Lymphocytes into Effector CTL. The Journal of Immunology. 172(11). 6558–6567. 65 indexed citations
3.
Kreuwel, Huub T. C., J Biggs, Ingrid M. Pilip, et al.. (2001). Defective CD8+ T Cell Peripheral Tolerance in Nonobese Diabetic Mice. The Journal of Immunology. 167(2). 1112–1117. 44 indexed citations
4.
Murtaza, Anwar, Pankaj Tailor, Valérie C. Asensio, et al.. (2001). Altered functional and biochemical response by CD8+ T cells that remain after tolerance. International Immunology. 13(8). 1085–1093. 5 indexed citations
5.
Morgan, David J., J Biggs, A.T.Y. Ko, et al.. (2000). Characterization of CD8+ T Lymphocytes That Persist After Peripheral Tolerance to a Self Antigen Expressed in the Pancreas. The Journal of Immunology. 164(1). 191–200. 52 indexed citations
6.
Sherman, Linda A., David J. Morgan, Javier Hernández, et al.. (2000). Self-Tolerance and the Composition of T Cell Repertoire. Immunologic Research. 21(2-3). 305–314. 12 indexed citations
7.
Sherman, Linda A., Matthias Theobald, David J. Morgan, et al.. (1998). Strategies for Tumor Elimination by Cytotoxic T Lymphocytes. Critical Reviews in Immunology. 18(1-2). 47–54. 28 indexed citations
8.
Theobald, Matthias, Thomas Ruppert, Ulrike Kuckelkorn, et al.. (1998). The Sequence Alteration Associated with a Mutational Hotspot in p53 Protects Cells From Lysis by Cytotoxic T Lymphocytes Specific for a Flanking Peptide Epitope. The Journal of Experimental Medicine. 188(6). 1017–1028. 98 indexed citations
9.
Theobald, Matthias, et al.. (1997). Tolerance to p53 by A2.1-restricted Cytotoxic T Lymphocytes. The Journal of Experimental Medicine. 185(5). 833–842. 226 indexed citations
10.
Theobald, Matthias, J Biggs, Dirk P. Dittmer, Arnold J. Levine, & Linda A. Sherman. (1995). Targeting p53 as a general tumor antigen.. Proceedings of the National Academy of Sciences. 92(26). 11993–11997. 247 indexed citations
11.
Chattopadhyay, Samit, Matthias Theobald, J Biggs, & Linda A. Sherman. (1994). Conformational differences in major histocompatibility complex-peptide complexes can result in alloreactivity.. The Journal of Experimental Medicine. 179(1). 213–219. 50 indexed citations
12.
Sherman, Linda A., Samit Chattopadhyay, J Biggs, Robert F. Dick, & Jeffrey A. Bluestone. (1993). Alloantibodies can discriminate class I major histocompatibility complex molecules associated with various endogenous peptides.. Proceedings of the National Academy of Sciences. 90(15). 6949–6951. 40 indexed citations
13.
Sherman, Linda A., Timothy Burke, & J Biggs. (1992). Extracellular processing of peptide antigens that bind class I major histocompatibility molecules.. The Journal of Experimental Medicine. 175(5). 1221–1226. 93 indexed citations
14.
Atkinson, K, et al.. (1987). CD4+ T cells appear capable of initiating graft-versus-host disease across non-major histocompatibility complex (MHC) barriers in man.. PubMed. 2(1). 79–84. 17 indexed citations
15.
Atkinson, K, et al.. (1987). Both class I and class II responsive T cell subsets can separately initiate lethal graft-versus-host disease in H-2-incompatible murine radiation chimeras.. PubMed. 19(2). 2876–8. 2 indexed citations
16.
Ting, A., et al.. (1986). The association of cytotoxic antidonor HLA antibodies and mismatched marrow graft rejection.. PubMed. 18(2). 264–6. 1 indexed citations
17.
Atkinson, K, et al.. (1985). Subsets of T lymphocyte subpopulations after human marrow transplantation defined by monoclonal antibodies and two-color fluorescence.. PubMed. 17(2). 1704–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026